Whan In Pharm Co.,Ltd. (KRX:016580)

South Korea · Delayed Price · Currency is KRW

10,870

+130 (1.21%)

Nov 13, 2026, 3:30 PM KST

Market Cap	200.92B +14.6%
Revenue (ttm)	273.47B +5.7%
Net Income	20.45B +24.6%
EPS	1,170.75 +9.0%
Shares Out	18.48M
PE Ratio	9.28
Forward PE	7.76
Dividend	300.00 (2.76%)
Ex-Dividend Date	Dec 29, 2026

Volume	23,445
Open	10,740
Previous Close	10,740
Day's Range	10,700 - 10,870
52-Week Range	9,160 - 12,140
Beta	0.12
Analysts	n/a
Price Target	n/a
Est. Earnings	Feb 12, 2027

About Whan In Pharm

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea. The company offers products, such as gastrointestinal, respiratory, cardiovascular, antidiabetic, antibiotic, antifungal, antihistamine, antiviral, antirheumatic, muscle relaxant, nonsteroidal anti-inflammatory, smoking cessation, erectile dysfunction, prostate disease, urinary disorder, osteoporosis, antiseizure, antidepressant, antipsychotic, central nervous system stimulant, anti-dementia, nootropic, alcohol use disorder, anti-Parkinson, multivitami... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1978

Employees 631

Stock Exchange Korea Stock Exchange

Ticker Symbol 016580

Full Company Profile

Financial Performance

In 2025, Whan In Pharm's revenue was 255.21 billion, a decrease of -1.69% compared to the previous year's 259.60 billion. Earnings were 13.60 billion, a decrease of -41.85%.

Financial Statements